Bacillus amyloliquefaciens and Antiviral Activity Against Singapore Grouper Iridovirus

• In vitro and in vivo evaluation of Bacillus amyloliquefaciens E35 as prophylactic agents against Singapore grouper iridovirus.

  • 2026-07
  • Clinical Trial
  • Fish & shellfish immunology 174
  • • Yanxia Gao
    • Lingling Deng
    • Yibing Wang
    • Lin Huang
    • Jieying Yu
    • Xiangmou Qin
    • Junxiang Lai
    • Ermeng Yu
    • Shuyuan Zhang
    • Ying Pan
    • Jiwei Xu
    • Qing Yu
    • Pengfei Li

  • PubMed: 41941900
  • DOI: 10.1016/j.fsi.2026.111318

  2 Insights on

  • Antiviral Activity Against Singapore Grouper Iridovirus

  • Moderate evidence

  E35 extracts had concentration dependent antiviral effects against SGIV in vitro... interfering with the adsorption, invasion and replication process of SGIV infection

  Effect

  Beneficial

  Effect size

  Moderate